AAAAAA

   
Results: 1-3 |
Results: 3
THE ORAL IRON CHELATOR DEFERIPRONE (L1) INHIBITS OXIDATION OF LDL ANDPROTECTS ENDOTHELIAL-CELLS AGAINST OXIDATIVE DAMAGE IN-VITRO
Authors: MURAR J DRAWZ P SHALEY O HEBBEL RP VERCELLOTTI GM
Citation: J. Murar et al., THE ORAL IRON CHELATOR DEFERIPRONE (L1) INHIBITS OXIDATION OF LDL ANDPROTECTS ENDOTHELIAL-CELLS AGAINST OXIDATIVE DAMAGE IN-VITRO, Blood, 86(10), 1995, pp. 503-503
AMELIORATION OF RED-CELL PATHOBIOLOGY AND HEMOLYSIS IN MURINE THALASSEMIA VIA DEFERIPRONE (L1)-MEDIATED REMOVAL OF RED-BLOOD-CELL MEMBRANE IRON
Authors: BROWNE PV SHALEY O CHOONG S SOLOVEY A SCHRIER S MOHANDAS N HEBBEL RP
Citation: Pv. Browne et al., AMELIORATION OF RED-CELL PATHOBIOLOGY AND HEMOLYSIS IN MURINE THALASSEMIA VIA DEFERIPRONE (L1)-MEDIATED REMOVAL OF RED-BLOOD-CELL MEMBRANE IRON, Blood, 86(10), 1995, pp. 1917-1917
THERAPY WITH THE ORAL IRON CHELATOR L1 REMOVES PATHOLOGICAL FREE IRONDEPOSITS FROM MEMBRANES OF INTACT SICKLE AND THALASSEMIC RBC
Authors: SHALEY O REPKA T GOLDFARB A GRINBERG L ABRAHAMOV A MARVA E OLIVIERI NF RACHMILEWITZ EA HEBBEL RP
Citation: O. Shaley et al., THERAPY WITH THE ORAL IRON CHELATOR L1 REMOVES PATHOLOGICAL FREE IRONDEPOSITS FROM MEMBRANES OF INTACT SICKLE AND THALASSEMIC RBC, Blood, 84(10), 1994, pp. 10000220-10000220
Risultati: 1-3 |